New inhaled compound aims to ease COPD breathing woes
NCT ID NCT06748079
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This early-stage trial is testing an experimental inhaled medication called TQC3721 in people with moderate to severe chronic obstructive pulmonary disease (COPD). The study aims to see how safe and tolerable the drug is, how it moves through the body, and what effects it has on lung function and symptoms. Participants will receive either the drug or a placebo, and some may also receive a combination with another inhaled medication. The results will help determine if this approach is worth further study as a potential COPD treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TQC3721 inhalation powder (a target inhibitor) given alone or with glyberlam inhalation powder, compared against placebo
- What this could lead to
- If safe and well-tolerated, TQC3721 could become a new inhaled treatment to help control COPD symptoms and improve quality of life.
- What could go wrong
- This is an early Phase 1 trial focused on safety and dosing, not yet on effectiveness. The drug may not work as hoped or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound might reveal hidden lung damage in COPD
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- Can a gentle nasal breeze unclog the Lungs' smallest airways?
- Can Home-Based lung rehab win over more COPD patients?
- Breathing battle: can simple exercises ease COPD symptoms?
- Can a drop of blood predict disease years before it strikes?